1. Home
  2. XMTR vs SYRE Comparison

XMTR vs SYRE Comparison

Compare XMTR & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xometry Inc.

XMTR

Xometry Inc.

SELL

Current Price

$62.91

Market Cap

3.2B

Sector

Technology

ML Signal

SELL

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$30.57

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XMTR
SYRE
Founded
2013
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.6B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
XMTR
SYRE
Price
$62.91
$30.57
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$55.11
$56.50
AVG Volume (30 Days)
745.4K
792.9K
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$642,780,000.00
N/A
Revenue This Year
$26.71
N/A
Revenue Next Year
$20.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.40
N/A
52 Week Low
$18.59
$10.91
52 Week High
$69.26
$35.31

Technical Indicators

Market Signals
Indicator
XMTR
SYRE
Relative Strength Index (RSI) 51.51 48.15
Support Level $59.41 $29.60
Resistance Level $69.00 $31.69
Average True Range (ATR) 3.23 1.49
MACD -0.04 -0.61
Stochastic Oscillator 38.30 38.96

Price Performance

Historical Comparison
XMTR
SYRE

About XMTR Xometry Inc.

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: